Download this slideset to review historical data for concurrent CRT compared to the latest clinical evidence for checkpoint inhibitor therapy in the care of patients with unresectable stage III NSCLC.
Download this slideset to see how our expert faculty would apply checkpoint inhibitor therapy in the treatment of a series of case patients with unresectable stage III NSCLC, including a frail patient, a patient with delayed recovery following concurrent CRT, and a patient with an actionable mutation.
Download this slideset to get up to date on clinical research being done to improve checkpoint inhibitor therapy for unresectable stage III NSCLC and to move it into resectable early-stage disease.
Watch this CME-certified Webcast of a live CCO symposium from the 2018 SITC Annual Meeting to get expert guidance on the optimal integration of immune checkpoint inhibition into treatment of stage III NSCLC, now and in the future.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.